Beijing Wandong Medical Technology Co Ltd
SSE:600055

Watchlist Manager
Beijing Wandong Medical Technology Co Ltd Logo
Beijing Wandong Medical Technology Co Ltd
SSE:600055
Watchlist
Price: 14.65 CNY -0.61% Market Closed
Market Cap: ¥10.3B

Balance Sheet

Balance Sheet Decomposition
Beijing Wandong Medical Technology Co Ltd

Balance Sheet
Beijing Wandong Medical Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
85
139
149
131
181
151
143
259
259
226
213
257
189
193
102
751
467
274
463
684
863
3 231
3 415
3 552
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
863
3 231
3 415
3 552
Cash Equivalents
85
139
149
131
181
151
143
259
259
226
213
257
189
193
102
751
467
274
463
683
0
0
0
0
Short-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255
345
347
234
450
246
100
4
0
Total Receivables
41
55
78
131
111
123
201
216
193
229
236
332
261
234
235
399
514
542
536
425
489
583
547
623
Accounts Receivables
26
46
72
118
93
107
176
191
170
198
207
287
215
207
188
167
295
286
259
156
202
313
270
383
Other Receivables
16
9
6
13
18
17
25
25
23
31
29
45
46
26
47
232
219
256
278
270
287
270
277
240
Inventory
144
169
185
215
231
208
198
174
169
207
214
256
212
192
182
135
175
192
188
246
192
267
378
215
Other Current Assets
10
5
12
27
14
16
12
12
11
12
30
51
104
126
188
13
90
102
65
60
70
85
61
62
Total Current Assets
280
368
424
504
537
498
554
662
632
674
693
896
766
745
707
1 552
1 591
1 457
1 486
1 865
1 861
4 266
4 404
4 451
PP&E Net
201
199
201
289
275
253
251
263
235
247
220
225
214
222
214
213
199
201
197
183
192
192
195
260
PP&E Gross
201
199
201
289
275
253
251
263
235
247
220
225
214
222
214
213
199
201
197
183
192
192
195
260
Accumulated Depreciation
96
109
119
124
121
131
141
107
94
110
104
156
166
174
187
151
129
128
125
138
156
173
189
224
Intangible Assets
4
10
11
9
8
6
7
7
10
9
12
45
76
82
91
84
70
59
62
47
32
20
27
61
Note Receivable
0
0
0
0
0
0
36
39
42
44
56
31
51
89
125
155
188
216
281
207
180
162
133
92
Long-Term Investments
17
18
27
25
36
36
37
43
43
22
25
25
18
22
17
17
85
299
308
480
528
523
549
515
Other Long-Term Assets
0
0
0
0
0
4
5
8
9
13
8
11
18
67
176
183
190
208
232
78
83
99
89
91
Total Assets
502
N/A
595
+18%
663
+11%
827
+25%
855
+3%
798
-7%
889
+12%
1 022
+15%
970
-5%
1 009
+4%
1 014
+1%
1 232
+21%
1 143
-7%
1 227
+7%
1 330
+8%
2 203
+66%
2 322
+5%
2 439
+5%
2 566
+5%
2 860
+11%
2 876
+1%
5 263
+83%
5 396
+3%
5 470
+1%
Liabilities
Accounts Payable
30
43
56
98
94
94
112
152
190
198
176
273
185
195
177
150
166
154
145
121
92
289
274
325
Accrued Liabilities
8
16
21
19
15
17
20
41
32
33
35
27
21
22
23
30
34
33
29
81
74
91
87
86
Short-Term Debt
74
102
102
172
219
176
230
279
126
111
142
134
141
208
230
36
85
93
99
97
102
27
24
30
Current Portion of Long-Term Debt
1
0
0
24
32
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
6
5
7
Other Current Liabilities
30
41
28
26
51
37
35
36
53
59
36
105
95
85
148
92
109
106
81
150
56
79
135
87
Total Current Liabilities
142
201
207
339
411
328
397
508
400
402
388
538
442
509
577
309
393
387
355
448
328
492
526
535
Long-Term Debt
5
5
24
41
9
4
4
4
4
4
4
4
4
4
4
4
4
4
0
0
14
16
11
15
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
Minority Interest
9
20
20
24
5
5
6
7
8
8
7
8
9
11
13
65
57
53
95
97
107
105
109
110
Other Liabilities
2
3
8
8
8
11
12
8
8
15
11
20
23
35
38
33
23
31
28
32
30
44
38
43
Total Liabilities
158
N/A
229
+44%
259
+13%
413
+60%
432
+5%
349
-19%
419
+20%
526
+26%
420
-20%
429
+2%
410
-4%
570
+39%
478
-16%
559
+17%
632
+13%
411
-35%
477
+16%
475
-1%
477
+1%
577
+21%
480
-17%
657
+37%
685
+4%
703
+3%
Equity
Common Stock
111
111
111
144
144
144
144
217
217
217
217
217
217
217
217
386
541
541
541
541
541
703
703
703
Retained Earnings
56
78
112
110
116
142
163
159
215
244
269
303
336
338
370
429
480
607
717
911
1 024
1 129
1 233
1 299
Additional Paid In Capital
177
177
180
159
163
163
163
120
120
119
119
142
113
113
113
977
822
822
883
883
883
2 775
2 778
2 770
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
51
51
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
5
1
2
1
2
3
5
Total Equity
344
N/A
367
+7%
404
+10%
414
+2%
423
+2%
449
+6%
470
+5%
495
+5%
551
+11%
580
+5%
604
+4%
662
+10%
666
+1%
668
+0%
699
+5%
1 792
+157%
1 844
+3%
1 965
+7%
2 089
+6%
2 283
+9%
2 396
+5%
4 605
+92%
4 711
+2%
4 768
+1%
Total Liabilities & Equity
502
N/A
595
+18%
663
+11%
827
+25%
855
+3%
798
-7%
889
+12%
1 022
+15%
970
-5%
1 009
+4%
1 014
+1%
1 232
+21%
1 143
-7%
1 227
+7%
1 330
+8%
2 203
+66%
2 322
+5%
2 439
+5%
2 566
+5%
2 860
+11%
2 876
+1%
5 263
+83%
5 396
+3%
5 470
+1%
Shares Outstanding
Common Shares Outstanding
485
485
485
485
485
485
485
485
485
485
485
485
485
485
485
541
541
541
541
541
536
703
703
703
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett